skip to main content
Idioma:
Mostrar Somente
Refinado por: Base de dados/Biblioteca: ROAD remover nível superior: Revistas revisadas por pares remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
158TiP Neoadjuvant abemaciclib and giredestrant trial in patients with ER-positive, HER2-negative early breast cancer (GIM31-Neo-AGILE trial)
158TiP Neoadjuvant abemaciclib and giredestrant trial in patients with ER-positive, HER2-negative early breast cancer (GIM31-Neo-AGILE trial)
Material Type:
Artigo 		Adicionar ao Meu Espaço

158TiP Neoadjuvant abemaciclib and giredestrant trial in patients with ER-positive, HER2-negative early breast cancer (GIM31-Neo-AGILE trial)

von Arx, C. ; Calabrese, A. ; Caputo, R. ; Di Lauro, V. ; Pensabene, M. ; Buono, G. ; Fabi, A. ; Cognetti, F. ; Guarneri, V. ; Puglisi, F. ; Vigneri, P. ; Del Mastro, L. ; Arpino, G. ; De Laurentiis, M.

ESMO open, 2024-05, Vol.9, p.103145, Article 103145 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
2
164P Circulating cytokines levels as predictive biomarkers in pleural mesothelioma: Preliminary data from a prospective translational study
164P Circulating cytokines levels as predictive biomarkers in pleural mesothelioma: Preliminary data from a prospective translational study
Material Type:
Artigo 		Adicionar ao Meu Espaço

164P Circulating cytokines levels as predictive biomarkers in pleural mesothelioma: Preliminary data from a prospective translational study

Scattolin, D. ; Urso, L. ; Cavallari, I. ; Ferro, A. ; Maso, A. Dal ; Frega, S. ; Bonanno, L. ; Guarneri, V. ; Pasello, G.

ESMO open, 2024-03, Vol.9, p.102740, Article 102740 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
3
1MO HER2DX assay and survival outcomes: An individual-patient level meta-analysis of 2,031 patients with HER2-positive breast cancer
1MO HER2DX assay and survival outcomes: An individual-patient level meta-analysis of 2,031 patients with HER2-positive breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

1MO HER2DX assay and survival outcomes: An individual-patient level meta-analysis of 2,031 patients with HER2-positive breast cancer

Javierre, G. Villacampa ; Cortés, J. ; García, J.M. Pérez ; Cussac, A. Llombart ; Tarantino, P. ; Conte, P.F. ; Mancino, M. ; Guarneri, V. ; Dieci, M.V. ; Waks, A. ; Brasó-Maristany, F. ; Pascual, T. ; Griguolo, G. ; Gonzalez, P. Villagrasa ; Parker, J. ; Vivancos, A. ; Perou, C.M. ; Brunet, L. Pare ; Prat, A. ; Tolaney, S.M.

ESMO open, 2024-05, Vol.9, p.103011, Article 103011 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
4
1MO Tumor immune microenvironment in ER-negative vs ER-low, HER2-neg breast cancer
1MO Tumor immune microenvironment in ER-negative vs ER-low, HER2-neg breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

1MO Tumor immune microenvironment in ER-negative vs ER-low, HER2-neg breast cancer

Massa, D. ; Vernieri, C. ; Nicolè, L. ; Criscitiello, C. ; Boissiere, F. ; Guiu, S. ; Bobrie, A. ; Griguolo, G. ; Miglietta, F. ; Vingiani, A. ; Lobefaro, R. ; Salimbeni, B. Taurelli ; Pruneri, G. ; Fassan, M. ; Curigliano, G. ; Guarneri, V. ; Jacot, W. ; Dieci, M.V.

ESMO open, 2023-05, Vol.8 (1), p.101225, Article 101225 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
5
206P Liver kinase B1 expression is associated with improved overall survival and decreased CD8+ tumor infiltrating lymphocytes in small cell lung cancer
206P Liver kinase B1 expression is associated with improved overall survival and decreased CD8+ tumor infiltrating lymphocytes in small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

206P Liver kinase B1 expression is associated with improved overall survival and decreased CD8+ tumor infiltrating lymphocytes in small cell lung cancer

Maso, A. Dal ; Ferrarini, F. ; Esposito, G. ; Pezzuto, F. ; Zulato, E. ; Bao, L.C. ; De Nuzzo, M. ; Ferro, A. ; Frega, S. ; Pasello, G. ; Calabrese, F. ; Fassan, M. ; Guarneri, V. ; Indraccolo, S. ; Bonanno, L.

ESMO open, 2024-03, Vol.9, p.102779, Article 102779 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
6
225P Platinum-based chemotherapy and PARP Inhibitors for BRCA mutated metastatic breast cancer (LATER-BC): Retrospective multicentre analysis of post-progression treatments
225P Platinum-based chemotherapy and PARP Inhibitors for BRCA mutated metastatic breast cancer (LATER-BC): Retrospective multicentre analysis of post-progression treatments
Material Type:
Artigo 		Adicionar ao Meu Espaço

225P Platinum-based chemotherapy and PARP Inhibitors for BRCA mutated metastatic breast cancer (LATER-BC): Retrospective multicentre analysis of post-progression treatments

Valenza, C. ; Trapani, D. ; Sposetti, C. ; Bielo, L. Boscolo ; Marra, A. ; Giarratano, T. ; Cortesi, L. ; Moscetti, L. ; Pistelli, M. ; Berardi, R. ; Zambelli, A. ; Guarneri, V. ; Vernieri, C. ; Curigliano, G.

ESMO open, 2023-05, Vol.8 (1), p.101414, Article 101414 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
7
33P Breast cancer brain metastases present a suppressed immune microenvironment enriched in macrophagic components as compared to paired primary tumors
33P Breast cancer brain metastases present a suppressed immune microenvironment enriched in macrophagic components as compared to paired primary tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

33P Breast cancer brain metastases present a suppressed immune microenvironment enriched in macrophagic components as compared to paired primary tumors

Griguolo, G. ; Tosi, A. ; Bottosso, M. ; Bauchet, L. ; Zanghi, F. ; Pellegrini, V. ; Miglietta, F. ; Rigau, V. ; Guarascio, M.C. ; Fassan, M. ; Jacot, W. ; Rosato, A. ; Guarneri, V. ; Darlix, A. ; Dieci, M.V.

ESMO open, 2024-05, Vol.9, p.103041, Article 103041 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
8
50P Circulating cytokines to predict pCR to neoadjuvant chemotherapy and nivolumab for ER+/HER2- BC: Analysis of the phase II GIADA trial
50P Circulating cytokines to predict pCR to neoadjuvant chemotherapy and nivolumab for ER+/HER2- BC: Analysis of the phase II GIADA trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

50P Circulating cytokines to predict pCR to neoadjuvant chemotherapy and nivolumab for ER+/HER2- BC: Analysis of the phase II GIADA trial

Dieci, M.V. ; Tosi, A. ; Bicciato, S. ; Bisagni, G. ; Musolino, A. ; Spazzapan, S. ; Vernaci, G.M. ; Griguolo, G. ; Giarratano, T. ; Miglietta, F. ; Urso, L. ; Schiavi, F. ; Pinato, C. ; De Salvo, G. ; Rosato, A. ; Guarneri, V.

ESMO open, 2024-05, Vol.9, p.103057, Article 103057 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
9
57P Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors
57P Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

57P Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors

Mosimann, F. Stella ; Varano, V. ; Tasca, G. ; Girardi, F. ; Tozzi, R. ; Massa, D. ; Zovato, S. ; Saccardi, C. ; Moserle, L. ; Montagna, M. ; Griguolo, G. ; Guarneri, V.

ESMO open, 2024-06, Vol.9, p.103564, Article 103564 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
10
5P HER2DX risk-score in HER2-positive (HER2+) breast cancer following neoadjuvant and adjuvant anti-HER2-based treatment: An updated survival analysis
5P HER2DX risk-score in HER2-positive (HER2+) breast cancer following neoadjuvant and adjuvant anti-HER2-based treatment: An updated survival analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

5P HER2DX risk-score in HER2-positive (HER2+) breast cancer following neoadjuvant and adjuvant anti-HER2-based treatment: An updated survival analysis

Saez, O. Martinez ; Brasó-Maristany, F. ; Griguolo, G. ; Brunet, L. Pare ; Dieci, M.V. ; Cortés, J. ; Cussac, A. Llombart ; Villacampa, G. ; Marín-Aguilera, M. ; Rey, M. ; Goberna, G. ; Munoz, M. ; Vivancos, A. ; Gonzalez, P. Villagrasa ; Parker, J. ; Conte, P.F. ; Prat, A. ; Pascual, T. ; Guarneri, V.

ESMO open, 2023-05, Vol.8 (1), p.101229, Article 101229 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Mostrar Somente

  1. Recursos Online (48)

Data de Publicação 

De até
Refinar
  1. Antes de2004  (6)
  2. 2004Até2008  (5)
  3. 2009Até2011  (4)
  4. 2012Até2016  (8)
  5. Após 2016  (27)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.